Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 304 participants.
Also called NCT01517373
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 304 participants
- Sponsor
- Registry
-
NCT01517373 -
2011-005206-30
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Bulgaria, Canada, Hungary, India, Slovakia, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01517373. Randomized; triple masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-01 (actual). Results posted on 2017-01-31.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- PF-04937319 10 mg
- Intervention (Drug)
- PF-04937319 50 mg
- Intervention (Drug)
- PF-04937319 100 mg
- Intervention (Drug)
- Glimepiride
- Lead sponsor
- Pfizer
Record details
- Record id
cardio:ct-nct01517373- Content hash
b2211f82680dfef28fe45235fc0a5c8cac5d2ba60389d46c73833ce4426b1b42